Michael Wilken

Title: Michael Wilken: Innovator in Immunology

Introduction

Michael Wilken is a notable inventor based in Hundested, Denmark. He has made significant contributions to the field of immunology, particularly through his work on human anti-KIR antibodies. With a total of two patents to his name, Wilken's innovations focus on enhancing immune responses in mammalian subjects.

Latest Patents

Wilken's latest patents describe compositions and methods for regulating an immune response. Specifically, these patents detail human antibodies that regulate the activity of natural killer (NK) cells. His work allows for the potentiation of NK cell cytotoxicity, which is crucial for therapeutic applications. The patents also cover fragments and derivatives of these antibodies, as well as pharmaceutical compositions that utilize them to increase NK cell activity or cytotoxicity in subjects.

Career Highlights

Throughout his career, Wilken has worked with esteemed institutions such as the University of Genoa and Innate Pharma S.a.s. His research has significantly advanced the understanding of immune regulation and therapeutic interventions.

Collaborations

Some of Wilken's notable coworkers include Alessandro Moretta and Mariella Della Chiesa. Their collaborative efforts have contributed to the advancements in the field of immunology.

Conclusion

Michael Wilken's innovative work in the development of human anti-KIR antibodies showcases his commitment to enhancing immune responses. His contributions are vital for future therapeutic applications in immunology.